These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 12964965)

  • 1. Increased expression of genes encoding mitochondrial proteins in papillary thyroid carcinomas.
    Haugen DR; Fluge Ø; Reigstad LJ; Varhaug JE; Lillehaug JR
    Thyroid; 2003 Jul; 13(7):613-20. PubMed ID: 12964965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Difference in patterns of Met expression in papillary thyroid carcinomas and nonneoplastic thyroid tissue.
    Fluge Ø ; Haugen DR; Lillehaug JR; Varhaug JE
    World J Surg; 2001 May; 25(5):623-31. PubMed ID: 11369990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of nicotinamide adenine dinucleotide phosphate oxidase flavoprotein DUOX genes and proteins in human papillary and follicular thyroid carcinomas.
    Lacroix L; Nocera M; Mian C; Caillou B; Virion A; Dupuy C; Filetti S; Bidart JM; Schlumberger M
    Thyroid; 2001 Nov; 11(11):1017-23. PubMed ID: 11762710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatocyte growth factor receptor, matrix metalloproteinase-11, tissue inhibitor of metalloproteinase-1, and fibronectin are up-regulated in papillary thyroid carcinoma: a cDNA and tissue microarray study.
    Wasenius VM; Hemmer S; Kettunen E; Knuutila S; Franssila K; Joensuu H
    Clin Cancer Res; 2003 Jan; 9(1):68-75. PubMed ID: 12538453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-wide expression analysis of Middle Eastern papillary thyroid cancer reveals c-MET as a novel target for cancer therapy.
    Siraj AK; Bavi P; Abubaker J; Jehan Z; Sultana M; Al-Dayel F; Al-Nuaim A; Alzahrani A; Ahmed M; Al-Sanea O; Uddin S; Al-Kuraya KS
    J Pathol; 2007 Oct; 213(2):190-9. PubMed ID: 17703498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thyroid transcription factor-1 in normal, hyperplastic, and neoplastic follicular thyroid cells examined by immunohistochemistry and nonradioactive in situ hybridization.
    Katoh R; Kawaoi A; Miyagi E; Li X; Suzuki K; Nakamura Y; Kakudo K
    Mod Pathol; 2000 May; 13(5):570-6. PubMed ID: 10824930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene expression profiling of differentiated thyroid neoplasms: diagnostic and clinical implications.
    Chevillard S; Ugolin N; Vielh P; Ory K; Levalois C; Elliott D; Clayman GL; El-Naggar AK
    Clin Cancer Res; 2004 Oct; 10(19):6586-97. PubMed ID: 15475448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression profile of malignant and non-malignant diseases of the thyroid gland reveals altered expression of a common set of genes in goiter and papillary carcinomas.
    Stolf BS; Abreu CM; Mahler-Araújo MB; Dellamano M; Martins WK; de Carvalho MB; Curado MP; Díaz JP; Fabri A; Brentani H; Carvalho AF; Soares FA; Kowalski LP; Hirata R; Reis LF
    Cancer Lett; 2005 Sep; 227(1):59-73. PubMed ID: 16051032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NATH, a novel gene overexpressed in papillary thyroid carcinomas.
    Fluge Ø; Bruland O; Akslen LA; Varhaug JE; Lillehaug JR
    Oncogene; 2002 Aug; 21(33):5056-68. PubMed ID: 12140756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of heregulins and associations with the ErbB family of tyrosine kinase receptors in papillary thyroid carcinomas.
    Fluge O; Akslen LA; Haugen DR; Varhaug JE; Lillehaug JR
    Int J Cancer; 2000 Sep; 87(6):763-70. PubMed ID: 10956383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of the sodium iodide symporter and thyroglobulin genes are reduced in papillary thyroid cancer.
    Ringel MD; Anderson J; Souza SL; Burch HB; Tambascia M; Shriver CD; Tuttle RM
    Mod Pathol; 2001 Apr; 14(4):289-96. PubMed ID: 11301345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expressions of human sodium iodide symporter mRNA in primary and metastatic papillary thyroid carcinomas.
    Park HJ; Kim JY; Park KY; Gong G; Hong SJ; Ahn IM
    Thyroid; 2000 Mar; 10(3):211-7. PubMed ID: 10779135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene profiling reveals specific oncogenic mechanisms and signaling pathways in oncocytic and papillary thyroid carcinoma.
    Baris O; Mirebeau-Prunier D; Savagner F; Rodien P; Ballester B; Loriod B; Granjeaud S; Guyetant S; Franc B; Houlgatte R; Reynier P; Malthiery Y
    Oncogene; 2005 Jun; 24(25):4155-61. PubMed ID: 15806164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The helix-loop-helix protein, Id-1, is overexpressed and regulates growth in papillary thyroid cancer.
    Kebebew E; Treseler PA; Duh QY; Clark OH
    Surgery; 2003 Aug; 134(2):235-41. PubMed ID: 12947323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The expression and role of serum response factor in papillary carcinoma of the thyroid.
    Kim HJ; Kim KR; Park HS; Jang KY; Chung MJ; Shong M; Moon WS
    Int J Oncol; 2009 Jul; 35(1):49-55. PubMed ID: 19513551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A metabolic phenotype based on mitochondrial ribosomal protein expression as a predictor of lymph node metastasis in papillary thyroid carcinoma.
    Lee J; Seol MY; Jeong S; Lee CR; Ku CR; Kang SW; Jeong JJ; Shin DY; Nam KH; Lee EJ; Chung WY; Jo YS
    Medicine (Baltimore); 2015 Jan; 94(2):e380. PubMed ID: 25590838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneous distribution of thyrotrophin receptor messenger ribonucleic acid (TSH-R mRNA) in papillary thyroid carcinomas detected by in situ hybridization.
    Tanaka K; Inoue H; Miki H; Komaki K; Monden Y
    Clin Endocrinol (Oxf); 1996 Mar; 44(3):259-67. PubMed ID: 8729520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular characterization of well-differentiated human thyroid carcinomas by cDNA arrays.
    Zhao J; Leonard C; Brunner E; Gemsenjäger E; Heitz PU; Odermatt B
    Int J Oncol; 2006 Nov; 29(5):1041-51. PubMed ID: 17016634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene expression profiles in thyroid carcinomas.
    Takano T; Hasegawa Y; Matsuzuka F; Miyauchi A; Yoshida H; Higashiyama T; Kuma K; Amino N
    Br J Cancer; 2000 Dec; 83(11):1495-502. PubMed ID: 11076659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RET/papillary thyroid cancer rearrangement in nonneoplastic thyrocytes: follicular cells of Hashimoto's thyroiditis share low-level recombination events with a subset of papillary carcinoma.
    Rhoden KJ; Unger K; Salvatore G; Yilmaz Y; Vovk V; Chiappetta G; Qumsiyeh MB; Rothstein JL; Fusco A; Santoro M; Zitzelsberger H; Tallini G
    J Clin Endocrinol Metab; 2006 Jun; 91(6):2414-23. PubMed ID: 16595592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.